Zi-Xian Liao

672 total citations
14 papers, 531 citations indexed

About

Zi-Xian Liao is a scholar working on Molecular Biology, Epidemiology and Biomaterials. According to data from OpenAlex, Zi-Xian Liao has authored 14 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Biomaterials. Recurrent topics in Zi-Xian Liao's work include RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and melanin and skin pigmentation (3 papers). Zi-Xian Liao is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and melanin and skin pigmentation (3 papers). Zi-Xian Liao collaborates with scholars based in Taiwan, China and Australia. Zi-Xian Liao's co-authors include Hsing‐Wen Sung, Ming-Cheng Wei, Shu‐Fen Peng, Yi‐Cheng Ho, Michael T. Tseng, Cherng‐Jyh Ke, Hsin‐Lung Chen, Wei‐Lun Chiang, Ping‐Shan Lai and Jui‐Sheng Sun and has published in prestigious journals such as Biomaterials, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Zi-Xian Liao

14 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zi-Xian Liao Taiwan 9 279 201 158 74 58 14 531
Nathaly Segovia Spain 5 305 1.1× 156 0.8× 143 0.9× 61 0.8× 45 0.8× 6 500
Catherine Passirani France 8 355 1.3× 286 1.4× 150 0.9× 61 0.8× 54 0.9× 8 616
Chengming Zhou China 12 183 0.7× 198 1.0× 120 0.8× 75 1.0× 31 0.5× 21 501
Julio M. Rios De La Rosa United Kingdom 10 272 1.0× 231 1.1× 213 1.3× 76 1.0× 55 0.9× 12 650
Marcin Wojnilowicz Australia 10 293 1.1× 159 0.8× 176 1.1× 34 0.5× 64 1.1× 17 520
Darío Manzanares Spain 8 291 1.0× 162 0.8× 146 0.9× 36 0.5× 116 2.0× 10 558
Shuquan Zheng China 15 552 2.0× 169 0.8× 171 1.1× 51 0.7× 27 0.5× 23 746
Pramod Kumar Ek Denmark 8 246 0.9× 199 1.0× 143 0.9× 60 0.8× 64 1.1× 9 500
Jia Cai China 10 203 0.7× 178 0.9× 231 1.5× 43 0.6× 56 1.0× 20 538
Junxiao Ye China 17 516 1.8× 229 1.1× 176 1.1× 50 0.7× 82 1.4× 23 864

Countries citing papers authored by Zi-Xian Liao

Since Specialization
Citations

This map shows the geographic impact of Zi-Xian Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Xian Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Xian Liao more than expected).

Fields of papers citing papers by Zi-Xian Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Xian Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Xian Liao. The network helps show where Zi-Xian Liao may publish in the future.

Co-authorship network of co-authors of Zi-Xian Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Xian Liao. A scholar is included among the top collaborators of Zi-Xian Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Xian Liao. Zi-Xian Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ou, Da‐Liang, Zi-Xian Liao, Ivan M. Kempson, et al.. (2024). Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer. Journal of Biomedical Science. 31(1). 1–1. 12 indexed citations
2.
Chen, Ming‐Han, et al.. (2022). Keratinocytes take part in the regulation of substance P in melanogenesis through the HPA axis. Journal of Dermatological Science. 106(3). 141–149. 7 indexed citations
3.
Liao, Zi-Xian, et al.. (2022). Peripheral benzodiazepine receptor TSPO needs to be reconsidered before using as a drug target for a pigmentary disorder. The FASEB Journal. 36(8). e22454–e22454. 1 indexed citations
4.
Tseng, S.‐Ja, Ivan M. Kempson, Zi-Xian Liao, Yi‐Cheng Ho, & Pan‐Chyr Yang. (2022). An acid degradable, lactate oxidizing nanoparticle formulation for non-small cell lung cancer virotherapy. Nano Today. 46. 101582–101582. 23 indexed citations
5.
Feng, Qingyuan, Meng Yu, Xiaofeng Zhang, et al.. (2022). Serotonin (5-HT) 2A Receptor Involvement in Melanin Synthesis and Transfer via Activating the PKA/CREB Signaling Pathway. International Journal of Molecular Sciences. 23(11). 6111–6111. 11 indexed citations
6.
Han, Jichun, Rui Zhang, Xiaofeng Zhang, et al.. (2021). Zebrafish Model for Screening Antiatherosclerosis Drugs. Oxidative Medicine and Cellular Longevity. 2021(1). 8 indexed citations
7.
Lo, Yu‐Lun, et al.. (2020). ROP and ATRP fabricated redox sensitive micelles based on PCL-SS-PMAA diblock copolymers to co-deliver PTX and CDDP for lung cancer therapy. Colloids and Surfaces B Biointerfaces. 198. 111443–111443. 31 indexed citations
8.
Liu, Wangta, Yu‐Lun Lo, Chin Hsu, et al.. (2019). CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC. Molecular Therapy — Nucleic Acids. 17. 477–490. 25 indexed citations
9.
Lo, Yu‐Lun, Hung‐Wei Wang, Zi-Xian Liao, & Li‐Fang Wang. (2016). The synthesis and comparison of chondroitin sulfate-modified PDMAEMA with chondroitin sulfate-modified PEI as a potential gene delivery vector. RSC Advances. 6(44). 38209–38222. 3 indexed citations
10.
Wan, Wei‐Lin, Zi-Xian Liao, Er‐Yuan Chuang, Chia‐Chen Lin, & Hsing‐Wen Sung. (2016). An aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy overcoming multidrug resistance. Nanomedicine Nanotechnology Biology and Medicine. 12(2). 480–480. 2 indexed citations
11.
Ke, Cherng‐Jyh, Wei‐Lun Chiang, Zi-Xian Liao, et al.. (2012). Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance. Biomaterials. 34(1). 1–10. 108 indexed citations
12.
Peng, Shu‐Fen, Chun‐Jen Su, Ming-Cheng Wei, et al.. (2010). Effects of the nanostructure of dendrimer/DNA complexes on their endocytosis and gene expression. Biomaterials. 31(21). 5660–5670. 58 indexed citations
13.
Chen, Fu‐Rong, et al.. (2010). Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials. 31(8). 2425–2434. 91 indexed citations
14.
Peng, Shu‐Fen, Michael T. Tseng, Yi‐Cheng Ho, et al.. (2010). Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(γ-glutamic acid) complexes as a gene delivery vector. Biomaterials. 32(1). 239–248. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026